MOB2
MOB kinase activator 2
Also known as: HCCA2, MOB2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q70IA6
- Gene
- MOB2
- Ensembl
- ENSG00000182208
- Chromosome
- 11
- Canonical length
- 237 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
Predicted to enable protein kinase activator activity. Predicted to be involved in signal transduction. Predicted to act upstream of or within actin cytoskeleton organization; positive regulation of neuron projection development; and positive regulation of protein phosphorylation. Located in cytosol; nucleolus; and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
237 residues, UniProt reviewed canonical sequence.
>Q70IA6|MOB2
1 MDWLMGKSKA KPNGKKPAAE ERKAYLEPEH TKARITDFQF KELVVLPREI DLNEWLASNT
61 TTFFHHINLQ YSTISEFCTG ETCQTMAVCN TQYYWYDERG KKVKCTAPQY VDFVMSSVQK
121 LVTDEDVFPT KYGREFPSSF ESLVRKICRH LFHVLAHIYW AHFKETLALE LHGHLNTLYV
181 HFILFAREFN LLDPKETAIM DDLTEVLCSG AGGVHSGGSG DGAGSGGPGA QNHVKERLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MOB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 79 nTPM
- colon: 68 nTPM
- urinary bladder: 49 nTPM
- skin: 46 nTPM
- skeletal muscle: 40 nTPM
- heart muscle: 34 nTPM
Single-cell type
- platelets: 357 nCPM
- esophageal apical cells: 265 nCPM
- vascular smooth muscle cells: 157 nCPM
- smooth muscle cells: 141 nCPM
- esophageal suprabasal cells: 84 nCPM
- suprabasal keratinocytes: 77 nCPM
Immune cell
- T-reg: 14 nTPM
- gdT-cell: 12 nTPM
- memory CD4 T-cell: 12 nTPM
- non-classical monocyte: 11 nTPM
- memory CD8 T-cell: 11 nTPM
- MAIT T-cell: 10 nTPM
Brain region
- medulla oblongata: 18 nTPM
- thalamus: 18 nTPM
- cerebellum: 16 nTPM
- midbrain: 16 nTPM
- basal ganglia: 16 nTPM
- cerebral cortex: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MOB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MOB2 as an antibody target. Whether an autoantibody or antibody against MOB2 could matter depends on whether native MOB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MOB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MOB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...